Diagnos Laboratorium Utama Tbk. vs Palma Serasih Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Palma Serasih Tbk. trades at Rp198 (market cap 3.71T, 76K 24h volume). The key difference: Palma Serasih Tbk. is far larger — about 11.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 76K). Which is the better fit depends on your goals.
| DGNS | PSGO | |
|---|---|---|
Market Cap | 310.75B | 3.71T |
Volume | 963.6K | 76K |
Lot | 9.64K | 760 |
Turnover | 217.67M | 14.92M |
Average Price | 225.89 | 196.31 |
Value | 217.67M | 14.92M |
Indicative Equilibrium Price | 226 | 196 |
Indicative Equilibrium Volume | 1K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Palma Serasih Tbk (the Company) was established in Jakarta based on Notarial Deed of Besri Zakaria,S.H. No.1 dated June 3, 2008. PT Jalinan kasih Sesama is the parent entity and the ultimate parent entity of the Group.
Read more on PSGO →